Table 1
Demographic and clinical characteristics of pulsatile and non-pulsatile CPB groups.
| Pulsatile group (n = 39) | Non-pulsatile group (n = 38) | p-Value | |
|---|---|---|---|
| Demographics | |||
| Age in years (Mean ± SD) | 35.5 ± 15.8 | 32 ± 16.1 | 0.34 |
| Males (%) | 12 (30.8%) | 13 (34.2%) | 0.81 |
| Weight (in kg) | 50.4 ± 17.7 | 47.3 ± 16.4 | 0.43 |
| Height (in cm) | 151.6 ± 22 | 147.7 ± 20 | 0.42 |
| BSA (m 2 ) | 1.62 [0.27] | 1.38 [0.38] | 0.039* |
| Clinical parameters | |||
| Urea (mg/dL) | 13.3 ± 5.4 | 11.6 ± 7.4 | 0.14 |
| Creatinine (mg/dL) | 0.8 ± 0.2 | 0.6 ± 0.3 | 0.011* |
| Total bilirubin (mg/dL) | 0.9 ± 0.5 | 1.16 ± 0.5 | 0.14 |
| Direct bilirubin (mg/dL) | 0.2 ± 0.2 | 0.2 ± 0.2 | 0.72 |
| SGOT (U/L) | 40.3 ± 28.5 | 39.2 ± 16.6 | 0.84 |
| SGPT (U/L) | 36.7 ± 17.8 | 33.3 ± 12.6 | 0.34 |
| ALP (U/L) | 84 | 66.25 | 0.75 |
Data are presented as mean ± SD or median [IQR] for continuous variables and n (%) for categorical variables. BSA, body surface area; SGOT, serum glutamic oxaloacetic transaminase; SGPT, serum glutamic pyruvic transaminase; ALP, alkaline phosphatase.
*p ≤ 0.05. Bold values indicate statistically significant differences between groups.
Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.
Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.
Initial download of the metrics may take a while.